119 related articles for article (PubMed ID: 1458620)
1. T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results.
Terhaard CH; Hordijk GJ; van den Broek P; de Jong PC; Snow GB; Hilgers FJ; Annyas BA; Tjho-Heslinga RE; de Jong JM
Clin Otolaryngol Allied Sci; 1992 Oct; 17(5):393-402. PubMed ID: 1458620
[TBL] [Abstract][Full Text] [Related]
2. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma of the supraglottic larynx without clinically detectable lymph node metastases: problem of local relapse and influence of overall treatment time.
Hoekstra CJ; Levendag PC; van Putten WL
Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):13-21. PubMed ID: 2298616
[TBL] [Abstract][Full Text] [Related]
4. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.
Spector JG; Sessions DG; Chao KS; Haughey BH; Hanson JM; Simpson JR; Perez CA
Head Neck; 1999 Dec; 21(8):707-17. PubMed ID: 10562683
[TBL] [Abstract][Full Text] [Related]
5. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
[TBL] [Abstract][Full Text] [Related]
7. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for survival in patients with T3 laryngeal carcinoma.
Manni JJ; Terhaard CH; de Boer MF; Croll GA; Hilgers FJ; Annyas AA; van der Meij AG; Hordijk GJ
Am J Surg; 1992 Dec; 164(6):682-7. PubMed ID: 1463124
[TBL] [Abstract][Full Text] [Related]
9. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
[TBL] [Abstract][Full Text] [Related]
10. Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term results.
Spector JG; Sessions DG; Emami B; Simpson J; Haughey B; Harvey J; Fredrickson JM
Laryngoscope; 1995 Apr; 105(4 Pt 1):397-406. PubMed ID: 7715386
[TBL] [Abstract][Full Text] [Related]
11. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
12. Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx.
Kligerman J; Olivatto LO; Lima RA; Freitas EQ; Soares JR; Dias FL; Melo LE; Sá GM; Duccini E
Am J Surg; 1995 Nov; 170(5):436-9. PubMed ID: 7485727
[TBL] [Abstract][Full Text] [Related]
13. Advanced carcinoma of the larynx: results of surgery and radiotherapy without induction chemotherapy (1980-1985): a multivariate analysis.
Nguyen TD; Malissard L; Théobald S; Eschwège F; Panis X; Bachaud JM; Rambert P; Chaplain G; Quint R
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1013-8. PubMed ID: 8985021
[TBL] [Abstract][Full Text] [Related]
14. Critical appraisal of watchful waiting policy in the management of N0 neck of advanced laryngeal carcinoma.
Yuen AP; Wei WI; Wong SH
Arch Otolaryngol Head Neck Surg; 1996 Jul; 122(7):742-5. PubMed ID: 8663947
[TBL] [Abstract][Full Text] [Related]
15. Nonnasopharyngeal lymphoepithelioma of the head and neck.
Dubey P; Ha CS; Ang KK; El-Naggar AK; Knapp C; Byers RM; Morrison WH
Cancer; 1998 Apr; 82(8):1556-62. PubMed ID: 9554534
[TBL] [Abstract][Full Text] [Related]
16. Radiation therapy for squamous cell carcinoma of the supraglottic larynx.
Shimm DS; Coulthard SW
Am J Clin Oncol; 1989 Feb; 12(1):17-23. PubMed ID: 2912019
[TBL] [Abstract][Full Text] [Related]
17. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery.
Spector JG; Sessions DG; Chao KS; Hanson JM; Simpson JR; Perez CA
Head Neck; 1999 Mar; 21(2):116-23. PubMed ID: 10091979
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in T3,N0-1 glottic and transglottic carcinoma. A multifactorial study of 221 cases treated by surgery or radiotherapy.
Kowalski LP; Batista MB; Santos CR; Scopel A; Salvajolli JV; Torloni H
Arch Otolaryngol Head Neck Surg; 1996 Jan; 122(1):77-82. PubMed ID: 8554750
[TBL] [Abstract][Full Text] [Related]
19. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
20. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL;
Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
